期刊文献+

宫颈细胞TBS+DNA倍体定量检测在宫颈病变中的应用

The purpose of cervical cells by TBS + DNA quantitative detection in cervical lesions
下载PDF
导出
摘要 目的:通过对宫颈细胞TBS+DNA倍体定量检测,及早发现宫颈病变,阻断宫颈癌的发生。方法:对妇科门诊就诊的1000例妇女进行宫颈细胞TBS+DNA倍体定量检测,阳性患者再做宫颈活检。诊断标准采用TBS分类系统。结果:1000例妇女宫颈刮片标本,TBS+DNA倍体定量检测阳性53例,阳性率为5.3%,其中不典型腺细胞(AGCUS)2例,低度鳞状上皮内病变(LSIL)40例,高度鳞状上皮内病变(HSIL)9例,鳞状细胞癌(SCC)2例。53例阳性者进行宫颈活检,其中轻度不典型腺上皮增生2例,CINⅠ39例,CINⅡ7例,CINⅢ3例,SCC2例。宫颈活检对TBS+DNA倍体检测提供的阳性病变加以确诊。30~40岁年龄阶段是CIN的高发年龄,发病率为56.6%(30/53)。结论:宫颈细胞TBS+DNA倍体定量测定与病理组织学有一定的相关性。TBS+DNA倍体定量测定作为无创伤检测是门诊筛查子宫颈癌的有效方法。对年轻妇女应特别关注宫颈癌的门诊筛查工作。 Objective: The purpose of cervical ceils by TBS + DNA ploidy quantitative detection, early detection of cervical lesions, blocked the occurrence of cervical cancer. Methods: Gynecology clinics of 1 000 cases of cervical cells, women in TBS + DNA ploidy quantitative tests in patients with positive cervical biopsy done. Diagnostic criteria for the use of TBS classification systems. Results: 1 000 cases of women in cervical scrape specimens films, TBS + DNA ploidy in 53 cases of positive quantitative detection, the positive rate was 5.3%, in which atypical glandular cells (AGCUS) 2 cases, low-grade squamous intraepithelial lesion (LSIL) 40 cases, a high degree of squamous intraepithelial lesion (HSIL) 9 cases of squamous cell carcinoma (SCC) 2 cases. Positive for 53 cases of cervical biopsy, which mild atypical glandular hyperplasia and 2 cases, CIN Ⅰ 39 cases, CIN Ⅱ 7 cases, CIN Ⅲ 3 cases, SCC 2 cases. Cervical biopsy of TBS + DNA ploidy provide positive detection of lesions to be diagnosed. Ages 30-40 years of age is the age of high incidence of CIN, the probability was 30/53 (56.6%). Conclusion:Cervical cells TBS+DNA ploidy and quantitative determination of some histological correlation. TBS+DNA quantitative determination of ploidy as a non-invasive detection of out-patient screening is an effective method for cervical cancer. Screening for cervical cancer patient to pay special attention to young women.
作者 樊精湛
出处 《中国当代医药》 2009年第15期167-168,共2页 China Modern Medicine
关键词 TBS+DNA倍体定量测定 宫颈癌 筛查 TBS+DNA ploidy quantitative determination Cervical cancer Screening
  • 相关文献

参考文献5

二级参考文献19

  • 1马武,张淑莲,宁艳.同步放化疗治疗宫颈癌的临床研究[J].现代肿瘤医学,2005,13(1):84-85. 被引量:17
  • 2[1]Benedet JL,Odicino F,Maisonneuve P,et al.Carcinoma of the Cervix Uteri FIGO annual report on the results of treatment in gynecological cancer[J].Int J Gynaecol Obstet,2003,83(Suppl 1:ix-xxii):41-78.
  • 3[2]Lorvidhaya V,Chitapanarux I,Sangruchi S,et al.Concurrent mitomycin C,5-fluorouracil,and radiotherapy in the treatment of locally advanced carcinoma of the cervix:a randomized trial[J].2003,55(5):1226-1232.
  • 4周建功,宋荣坡.动脉栓塞化疗和放疗结合治疗中晚期宫颈癌[J].中国现代医生,2007,45(09Z):4-5. 被引量:8
  • 5Andrawiss M. Cervical cancer vaccines available in 2005 [ J ]. Drug Discov Today,2005, 10(14) :949-950.
  • 6JU Xing-zhu, YANG Jin-ming, ZHOU Xiao-yan, et al. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer [ J]. Clinical Cancer Research,2008,14 (2) :494-495.
  • 7Suba E J, Raab S S, Frable W J, et al. Cost-effectiveness of cervical cancer screening in developing countries [ J ]. N Engl J Med, 2006, 354 : 1535-1536.
  • 8Suba E J, Raab S S. Viet/American cervical cancer prevention project, papanicolaou screening in developing countries: An idea whose time has come[J]. Am J Clin Pathol,2004,121:315-320.
  • 9Cuzick J, Szarewski A, Cubie H, et al. Management of women who test positive for high-risk types of human papillomavirus: The HART study[J]. Lancet,2003,362:1871-1876.
  • 10Marij J P W, Gemma G K, Sytse J P, et al. Induction of tumorspecific CD4^+ and CD8^+ T-Cell immunity in cervical cancer patients by a Human Papillomavirus type 16 E6 and E7 long peptides vaccine [ J]. Clinical Cancer Research,2008,14 ( 1 ) : 178-187.

共引文献183

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部